FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Nonprescription Drug Labeling Changes Draft Guide

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Annual Reportable Labeling Changes for NDAs and ANDAs for N...

Draft Guide on Device Cybersecurity

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Select Updates for the Premarket Cybersecurity Guidance: Se...

Pharmaceutical Science Advisory Panel Renewed

[ Price : $8.95]

Federal Register notice: FDA renews its Pharmaceutical Science and Clinical Pharmacology Advisory Committee for an additional two ...

Help Industry with Bad Labs: Post

[ Price : $8.95]

A Hyman, Phelps & McNamara medical device regulatory expert and attorney say FDA should help industry learn how to avoid labs that...

QS, MDR Issues Seen in Exactech Inspection

[ Price : $8.95]

FDA warns Gainesville, FL-based Exactech about Quality System and Medical Device Report violations in its manufacturing of orthope...

Minor Drug Labeling Change Reporting Guide

[ Price : $8.95]

FDA publishes a draft guidance with recommendations for NDA and ANDA applicants for nonprescription drugs to document minor labeli...

False or Misleading Senvelgo Claims: CVM

[ Price : $8.95]

CVM warns Boehringer Ingelheim Animal Health USA that promotional communications for its Senvelgo make false and misleading claims...

Cybersecurity Guidance Updates Proposed

[ Price : $8.95]

FDA publishes a draft guidance proposing select updates to its existing premarket cybersecurity guidance.

Digital Drug Marketing Workshop Themes

[ Price : $8.95]

A Duke-Margolis Institute for Health Policy report on an FDA-funded virtual workshop on drug digital marketing identifies several ...

Most MDRs Hit Device Function Issues: Study

[ Price : $8.95]

FDA and Instem researchers say 92% of Medical Device Reports filed between 2011 and 2021 involved device issues rather than patien...